npj Breast Cancer (Jun 2021)

Risk of primary lung cancer after adjuvant radiotherapy in breast cancer—a large population-based study

  • Anna-Karin Wennstig,
  • Charlotta Wadsten,
  • Hans Garmo,
  • Mikael Johansson,
  • Irma Fredriksson,
  • Carl Blomqvist,
  • Lars Holmberg,
  • Greger Nilsson,
  • Malin Sund

DOI
https://doi.org/10.1038/s41523-021-00280-2
Journal volume & issue
Vol. 7, no. 1
pp. 1 – 8

Abstract

Read online

Abstract Adjuvant radiotherapy (RT) for breast cancer (BC) has been associated with an increased risk of later radiation-induced lung cancer (LC). We examined the risk of primary LC in a population-based cohort of 52300 women treated for BC during 1992 to 2012, and 253796 age-matched women without BC. Cumulative incidence of LC was calculated by the Kaplan–Meier method, and the risk of LC after BC treatment was estimated by Cox proportional hazards regression analyses. Women with BC receiving RT had a higher cumulative incidence of LC compared to women with BC not receiving RT and women without BC. This became apparent 5 years after RT and increased with longer follow-up. Women with BC receiving RT had a Hazard ratio of 1.59 (95% confidence interval 1.37–1.84) for LC compared to women without BC. RT techniques that lower the incidental lung doses, e.g breathing adaption techniques, may lower this risk.